See all treatments in the PatientsLikeMe system shared by patients just like you.
What is Entacapone? Entacapone is COMT inhibitor drug which enhances the transport of l-dopa to the brain, improving the efficacy of l-dopa containing drugs such as Sinemet.
See more information, including instructions, precautions, side effects, and interactions.
112 patients in the community are taking or have taken Entacapone.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat Parkinson's | 81 | 72% |
| Stiffness/spasticity | 6 | 5% |
| Other | 6 | 5% |
| Support another treatment | 4 | 3% |
| disease-related symptoms | 1 | <1% |
| Slowness | 1 | <1% |
How long current patients have been taking Entacapone or how long patients were taking Entacapone before stopping.
Results from 6 patient evaluations. See the overall results and all individual evaluations.
| Major | 20% | 1 |
|---|---|---|
| Moderate | 40% | 2 |
| Slight | 20% | 1 |
| Can't tell | 20% | 1 |
Treat Parkinson's
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 33% | 2 |
| None | 67% | 4 |
Top reported side-effects include: Increased dyskenisia
Summary results are based on 6 individual responses. For more information, see overall results for Adherence, Burden and Cost.